Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 017493

Expand all

RENAMIN W/O ELECTROLYTES (AMINO ACIDS)
6.5% (6.5GM/100ML)
Marketing Status: Discontinued

Active Ingredient: AMINO ACIDS
Proprietary Name: RENAMIN W/O ELECTROLYTES
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 6.5% (6.5GM/100ML)
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N017493
Product Number: 007
Approval Date: Oct 15, 1982
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:  Discontinued
Patent and Exclusivity Information

TRAVASOL 10% W/O ELECTROLYTES (AMINO ACIDS)
10% (10GM/100ML)
Marketing Status: Discontinued

Active Ingredient: AMINO ACIDS
Proprietary Name: TRAVASOL 10% W/O ELECTROLYTES
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 10% (10GM/100ML)
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N017493
Product Number: 006
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:  Discontinued
Patent and Exclusivity Information

TRAVASOL 5.5% W/O ELECTROLYTES (AMINO ACIDS)
5.5% (5.5GM/100ML)
Marketing Status: Discontinued

Active Ingredient: AMINO ACIDS
Proprietary Name: TRAVASOL 5.5% W/O ELECTROLYTES
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 5.5% (5.5GM/100ML)
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N017493
Product Number: 004
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:  Discontinued
Patent and Exclusivity Information

TRAVASOL 8.5% W/O ELECTROLYTES (AMINO ACIDS)
8.5% (8.5GM/100ML)
Marketing Status: Discontinued

Active Ingredient: AMINO ACIDS
Proprietary Name: TRAVASOL 8.5% W/O ELECTROLYTES
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 8.5% (8.5GM/100ML)
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N017493
Product Number: 005
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:  Discontinued
Patent and Exclusivity Information

TRAVASOL 3.5% W/ ELECTROLYTES (AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE)
3.5%;51MG/100ML;131MG/100ML;218MG/100ML;35MG/100ML
Marketing Status: Discontinued

Active Ingredient: AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE
Proprietary Name: TRAVASOL 3.5% W/ ELECTROLYTES
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 3.5%;51MG/100ML;131MG/100ML;218MG/100ML;35MG/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N017493
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:  Discontinued
Patent and Exclusivity Information

TRAVASOL 5.5% W/ ELECTROLYTES (AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE)
5.5%;102MG/100ML;522MG/100ML;431MG/100ML;224MG/100ML
Marketing Status: Discontinued

Active Ingredient: AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE
Proprietary Name: TRAVASOL 5.5% W/ ELECTROLYTES
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 5.5%;102MG/100ML;522MG/100ML;431MG/100ML;224MG/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N017493
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:  Discontinued
Patent and Exclusivity Information

TRAVASOL 8.5% W/ ELECTROLYTES (AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE)
8.5%;102MG/100ML;522MG/100ML;594MG/100ML;154MG/100ML
Marketing Status: Discontinued

Active Ingredient: AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE
Proprietary Name: TRAVASOL 8.5% W/ ELECTROLYTES
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 8.5%;102MG/100ML;522MG/100ML;594MG/100ML;154MG/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N017493
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:  Discontinued
Patent and Exclusivity Information